Fundraising Fox
/People
Sign in

Maria Fardis

Investor

Venture Partner at Frazier Life Sciences · Venture Partner at Frazier Healthcare Partners · Executive at AirNexis Therapeutics · CEO at Lassen Therapeutics · Board director at Quanta Therapeutics

Palo Alto

Find your path to Maria

611 people in our graph can introduce you to Maria.

Each arrow is one introduction. Sign up to fill in the first one.

Ask David Steinberg to introduce you to Maria

You →David · together at Lassen Therapeutics (2023) →Maria

Ask Jamie Chen to introduce you to Maria

You →Jamie · together at Lassen Therapeutics →Maria

Ask Sam Okafor to introduce you to Maria

You →Sam · together at Kartosthera →Maria

Sign up to find every way you can get introduced to Maria

  • Your email: the people you already email who know Maria
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Maria
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Maria Fardis joined Frazier Life Sciences as a Venture Partner in 2021 and has more than 20 years of scientific and management experience across public and private companies. She currently serves as CEO of Lassen Therapeutics and previously held leadership roles including President and CEO of Iovance Biotherapeutics, COO of Acerta Pharma, and senior positions at Pharmacyclics and Gilead Sciences. She holds a Ph.D. in Organic Chemistry from UC Berkeley, a B.S. in chemistry from the University of Illinois, Urbana-Champaign, and an M.B.A. from Golden Gate University.

Invests in

Biotech

Executive at AirNexis Therapeutics

Intro paths

→

In turn, Maria can intro founders to AirNexis Therapeutics's investors below.

AirNexis Therapeutics's investors · 4

Frazier Life SciencesPalo Alto · since 2026Longitude CapitalMenlo Park · $10M – $30M checks · since 2026OrbiMedNew York · $1M – $75M checks · since 2026SR One Capital ManagementRedwood City · since 2026

CEO at Lassen Therapeutics

Intro paths

→

In turn, Maria can intro founders to Lassen Therapeutics's investors below.

Lassen Therapeutics's investors · 9

Alta PartnersJackson · $1M – $12M checks · since 2024Biotechnology Value FundSan Francisco · since 2024Catalio Capital ManagementNew York · since 2024Catalio Capital Management, LPNew YorkDC Investment PartnersMcLean · $10M checksFrazier Healthcare PartnersSeattle · $50M – $400M checks · since 2020Frazier Life SciencesPalo Alto · since 2024Longitude CapitalMenlo Park · $10M – $30M checks · since 2024Longwood FundBoston · since 2024

Co-founders at Lassen Therapeutics

DKDavid King
David KingCo-Founder & CSO

Board director at Quanta Therapeutics

Intro paths

→

In turn, Maria can intro founders to Quanta Therapeutics's investors below.

Quanta Therapeutics's investors · 6

Biotechnology Value FundSan Francisco · since 2023Finchley Healthcare VenturesMontrealFrazier Life SciencesPalo Alto · since 2023Longitude CapitalMenlo Park · $10M – $30M checks · since 2023Sofinnova VenturesMenlo Park · $100K – $15M checks · since 2026Vida VenturesLos Angeles · since 2023

Experience

  1. AirNexis Therapeutics Inc.Chief Executive Officercurrent2026 — present
  2. CRISPR TherapeuticsMember Board Of Directorscurrent2022 — presentCambridge, Massachusetts, United States
  3. Obsidian TherapeuticsChair Of The Board Of Directorscurrent2021 — presentCambridge, Massachusetts, United States
  4. Frazier Healthcare PartnersVenture Partnercurrent2021 — presentSan Francisco Bay Area
  5. Quanta TherapeuticsMember Board of Directorscurrent2021 — presentSouth San Francisco, California, United States
  6. Lassen TherapeuticsChief Executive Officer2023 — 2026San Diego, CA
  7. Kartos TherapeuticsMember Board Of Directors2018 — 2021Redwood Shores
  8. Iovance Biotherapeutics, Inc.President & Chief Executive Officer2016 — 2021San Francisco Bay Area
  9. Acerta Pharma B.V.Chief Operating Officer2015 — 2016San Carlos, CA
  10. PharmacyclicsChief of Oncology Operations and Alliances2013 — 2014Sunnyvale, CA
  11. PharmacyclicsEVP of Operations and Alliances2012 — 2013
  12. PharmacyclicsVP, Alliances and Global Project Management2011 — 2012Sunnyvale, CA
  13. PharmacyclicsSenior Director, Global Project Management2011Sunnyvale, CA
  14. Gilead SciencesAssociate Director, Project and Portfolio Management2010 — 2011
  15. Gilead SciencesSenior Manager, Project and Portfolio Management2006 — 2010
  16. Gilead SciencesSenior Scientist, Medicinal Chemistry2005 — 2006
  17. Gilead SciencesScientist II, Medicinal Chemistry2004 — 2005
  18. Gilead SciencesScientist, Medicinal Chemistry2001 — 2004
  19. Intrabiotics PharmaceuticalsScientist, Medicinal Chemistry2001
  20. Kosan Biosciences acquired by Brisol-Myers SquibbScientist, Medicinal Chemistry1998 — 2000
  21. UC BerkeleyGraduate Student1993 — 1998

Skills & more

BiotechnologyIND45Clinical DevelopmentClinical Trials86Clinical Research46Project Management37Pharmaceutical Industry90OncologyLifesciences18GMP19Cancer30Drug Discovery23
+8 moreMedicinal ChemistryGCPRegulatory AffairsCTMSDrug DevelopmentCross-functional Team LeadershipCROBiopharmaceuticals

From Maria's professional profile.

Deals · 1

Quanta TherapeuticsBoard seat

via Frazier Life Sciences · filed Jun 2026 · $89.1M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Frazier Life Sciences

Adam Simpson
Venture Partner at Frazier Life Sciences
Aditya Kohli
Partner at Frazier Life Sciences
Alan Frazier
Chairman Emeritus at Frazier Life Sciences
Albert Cha
Managing Partner at Frazier Life Sciences
Ali Jackson
Vice President and Counsel, Public Funds at Frazier Life Sciences
Amanda Wilson
Senior Tax Manager at Frazier Life Sciences
Angel Martin
Senior Associate at Frazier Life Sciences
Angie You
Senior Advisor at Frazier Life Sciences

Frequently asked questions

Who is Maria Fardis?
Maria Fardis joined Frazier Life Sciences as a Venture Partner in 2021 and has more than 20 years of scientific and management experience across public and private companies. She currently serves as CEO of Lassen Therapeutics and previously held leadership roles including President and CEO of Iovance Biotherapeutics, COO of Acerta Pharma, and senior positions at Pharmacyclics and Gilead Sciences. She holds a Ph.D. in Organic Chemistry from UC Berkeley, a B.S. in chemistry from the University of Illinois, Urbana-Champaign, and an M.B.A. from Golden Gate University.
Where does Maria Fardis work?
Maria Fardis is Venture Partner at Frazier Life Sciences and Executive at AirNexis Therapeutics and CEO at Lassen Therapeutics and Board director at Quanta Therapeutics.
What does Maria Fardis invest in?
Maria Fardis invests in Biotech.
What boards does Maria Fardis sit on?
Maria Fardis holds tracked board seats at Quanta Therapeutics.
Where did Maria Fardis go to school?
Maria Fardis studied at Golden Gate University (MBA, Management); University of California, Berkeley (Ph.D., Organic Chemistry); University of Illinois Urbana-Champaign (B.S., Organic Chemistry, summa cum laude).

Founder mafias

Same school

Shared employers